High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+T-cell response: Implications for the initiation of autoimmune response in multiple sclerosis

被引:35
作者
Markovic-Plese, S [1 ]
Hemmer, B
Zhao, YD
Simon, R
Pinilla, C
Martin, R
机构
[1] Univ N Carolina, Dept Neurol, Chapel Hill, NC 27599 USA
[2] NINDS, Neuroimmunol Branch, NIH, Bethesda, MD 20892 USA
[3] Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, Germany
[4] NCI, Biometr Res Branch, NIH, Rockville, MD 20854 USA
[5] Torrey Pines Inst Mol Studies & Mixture Sci, San Diego, CA 92121 USA
[6] Hosp Univ Vall dHebron, Neuroimmunol Clin, Barcelona 08035, Spain
关键词
multiple sclerosis; influenza haemagglutinin; immunodominant epitope; molecular mimicry; T-cell receptor repertoire;
D O I
10.1016/j.jneuroim.2005.07.014
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Viral infections play a role in shaping and maintaining the peripheral T-cell repertoire, as well as ill the initiation Of autoimmune response via mechanisms of molecular mimicry. Ill this Study, we addressed the flexibility of T-cell receptor (TCR) recognition and the degree of structural and sequence homology required for cross-reactive immune response in the induction of autoimmune response. We Studied the extent of cross-reactivity of a CD4+ T-cell clone (TCC) specific for the immunodominant influenza virus hemagglutinin (Flu-HA) peptide derived from a patient with multiple sclerosis (MS) using positional scanning synthetic peptide combinatorial libraries (PS-SCL). We documented cross-reactivity against 14 Flu-HA variants, 11 viral, 15 human, and 3 myelin-derived peptides. Moreover, we identified six naturally Occurring peptides with higher stimulatory potency than the native ligand, implicating high potential for cross-reactivity even for a virus-specific memory TCC. Our Study demonstrates that flexibility of TCR recognition is present even in a clone with a high degree of TCR specificity for all infectious agent. The results have implications for vaccine design and for antigen-specific treatment strategies for autoimmune diseases. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:31 / 38
页数:8
相关论文
共 25 条
[1]   Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand [J].
Bielekova, B ;
Goodwin, B ;
Richert, N ;
Cortese, I ;
Kondo, T ;
Afshar, G ;
Gran, B ;
Eaton, J ;
Antel, J ;
Frank, JA ;
McFarland, HF ;
Martin, R .
NATURE MEDICINE, 2000, 6 (10) :1167-1175
[2]  
Borràs E, 2002, J IMMUNOL METHODS, V267, P81
[3]   Size estimate of the αβ TCR repertoire of naive mouse splenocytes [J].
Casrouge, A ;
Beaudoing, E ;
Dalle, S ;
Pannetier, C ;
Kanellopoulos, J ;
Kourilsky, P .
JOURNAL OF IMMUNOLOGY, 2000, 164 (11) :5782-5787
[4]   STRUCTURE OF PEPTIDES ASSOCIATED WITH MHC CLASS-I MOLECULES [J].
ENGELHARD, VH .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (01) :13-23
[5]   Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease [J].
Evans, CF ;
Horwitz, MS ;
Hobbs, MV ;
Oldstone, MBA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (06) :2371-2384
[6]   TRANSGENIC MICE THAT EXPRESS A MYELIN BASIC PROTEIN-SPECIFIC T-CELL RECEPTOR DEVELOP SPONTANEOUS AUTOIMMUNITY [J].
GOVERMAN, J ;
WOODS, A ;
LARSON, L ;
WEINER, LP ;
HOOD, L ;
ZALLER, DM .
CELL, 1993, 72 (04) :551-560
[7]  
Hemmer B, 1999, NAT MED, V5, P1375
[8]   Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone [J].
Hemmer, B ;
Fleckenstein, BT ;
Vergelli, M ;
Jung, G ;
McFarland, H ;
Martin, R ;
Wiesmuller, KH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (09) :1651-1659
[9]  
Hemmer B, 1998, J IMMUNOL, V160, P3631